Literature DB >> 32370763

Cost of illness for childhood diarrhea in low- and middle-income countries: a systematic review of evidence and modelled estimates.

Ranju Baral1, Justice Nonvignon2,3, Frédéric Debellut4, Samuel Agyei Agyemang2, Andrew Clark5, Clint Pecenka6.   

Abstract

BACKGROUND: Numerous studies have reported the economic burden of childhood diarrhea in low- and middle-income countries (LMICs). Yet, empirical data on the cost of diarrheal illness is sparse, particularly in LMICs. In this study we review the existing literature on the cost of childhood diarrhea in LMICs and generate comparable estimates of cost of diarrhea across 137 LMICs.
METHODS: The systematic literature review included all articles reporting cost estimates of diarrhea illness and treatment from LMICs published between January 2006 and July 2018. To generate country-specific costs, we used service delivery unit costs from the World Health Organization's Choosing Interventions that are Cost-Effective (WHO-CHOICE database). Non-medical costs were calculated using the ratio between direct medical and direct non-medical costs, derived from the literature review. Indirect costs (lost wages to caregivers) were calculated by multiplying the average GDP per capita per day by the average number of days lost to illness identified from the literature. All cost estimates are reported in 2015 USD. We also generated estimates using the IHME's service delivery unit costs to explore input sensitivity on modelled cost estimates.
RESULTS: We identified 25 articles with 64 data points on either direct or indirect cost of diarrhoeal illness in children aged < 5 years in 20 LMICs. Of the 64 data points, 17 were on the cost of outpatient care, 28 were on the cost of inpatient care, and 19 were unspecified. The average cost of illness was US$36.56 (median $15.73; range $4.30 - $145.47) per outpatient episode and $159.90 (median $85.85; range $41.01 - $538.33) per inpatient episode. Direct medical costs accounted for 79% (83% for inpatient and 74% for outpatient) of the total direct costs. Our modelled estimates, across all 137 countries, averaged (weighted) $52.16 (median $47.56; range $8.81 - $201.91) per outpatient episode and $216.36 (median $177.20; range $23.77 -$1225.36) per inpatient episode. In the 12 countries with primary data, there was reasonable agreement between our modelled estimates and the reported data (Pearson's correlation coefficient = .75).
CONCLUSION: Our modelled estimates generally correspond to estimates observed in the literature, with a few exceptions. These estimates can serve as useful inputs for planning and prioritizing appropriate health interventions for childhood diarrheal diseases in LMICs in the absence of empirical data.

Entities:  

Keywords:  Cost; Cost of illness; Diarrhea

Year:  2020        PMID: 32370763     DOI: 10.1186/s12889-020-08595-8

Source DB:  PubMed          Journal:  BMC Public Health        ISSN: 1471-2458            Impact factor:   3.295


  11 in total

Review 1.  Is the Medium Still the Message? Culture-Independent Diagnosis of Gastrointestinal Infections.

Authors:  Neil Sood; Gary Carbell; Holly S Greenwald; Frank K Friedenberg
Journal:  Dig Dis Sci       Date:  2021-11-30       Impact factor: 3.199

2.  Spatiotemporal patterns of diarrhea incidence in Ghana and the impact of meteorological and socio-demographic factors.

Authors:  Ernest O Asare; Joshua L Warren; Virginia E Pitzer
Journal:  Front Epidemiol       Date:  2022-04-08

Review 3.  Paediatrics: how to manage viral gastroenteritis.

Authors:  Alexander Kc Leung; Kam Lun Hon
Journal:  Drugs Context       Date:  2021-03-26

4.  Efficacy and safety of Bacillus clausii (O/C, N/R, SIN, T) probiotic combined with oral rehydration therapy (ORT) and zinc in acute diarrhea in children: a randomized, double-blind, placebo-controlled study in India.

Authors:  Keya Rani Lahiri; Raghvendra Singh; Mohini Apte; Mahantesh Patil; Amar Taksande; Rafael Varona; Godhuli Chatterjee; Manish Verma; Sandrine Brette; Marcos Iii Perez
Journal:  Trop Dis Travel Med Vaccines       Date:  2022-04-10

5.  A Nighttime Telemedicine and Medication Delivery Service to Avert Pediatric Emergencies in Haiti: An Exploratory Cost-Effectiveness Analysis.

Authors:  Katelyn E Flaherty; Molly B Klarman; Youseline Cajusma; Justin Schon; Lerby Exantus; Valery M Beau de Rochars; Chantale Baril; Torben K Becker; Eric J Nelson
Journal:  Am J Trop Med Hyg       Date:  2022-02-21       Impact factor: 2.345

6.  Direct and indirect costs of acute diarrhea in children under five years of age in Indonesia: Health facilities and community survey.

Authors:  Jarir At Thobari; Asal Wahyuni Erlin Mulyadi; Emma Watts; Natalie Carvalho; Frédéric Debellut; Andrew Clark; Yati Soenarto; Julie E Bines
Journal:  Lancet Reg Health West Pac       Date:  2021-12-13

7.  Potential impact and cost-effectiveness of injectable next-generation rotavirus vaccines in 137 LMICs: a modelling study.

Authors:  Frédéric Debellut; Clint Pecenka; William P Hausdorff; Andrew Clark
Journal:  Hum Vaccin Immunother       Date:  2022-03-03       Impact factor: 4.526

8.  Cost-effectiveness of rotavirus vaccination in Mozambique.

Authors:  Esperança Lourenço Guimarães; Assucênio Chissaque; Clint Pecenka; Andrew Clark; Basília Vaz; Arlindo Banze; Neide Canana; Clésio Romão; Maria do Rosário Oliveira Martins; Nilsa de Deus; Frédéric Debellut
Journal:  Vaccine       Date:  2022-08-03       Impact factor: 4.169

9.  Diarrhea hospitalization costs among children <5 years old in Madagascar.

Authors:  Eleanor Burnett; Vonintsoa Lalaina Rahajamanana; Julia Liliane Raboba; Goitom Weldegebriel; Yolande Vuo Masembe; Jason M Mwenda; Umesh D Parashar; Jacqueline E Tate; Annick Lalaina Robinson
Journal:  Vaccine       Date:  2020-10-10       Impact factor: 3.641

10.  Which Probiotic Is the Most Effective for Treating Acute Diarrhea in Children? A Bayesian Network Meta-Analysis of Randomized Controlled Trials.

Authors:  Zengbin Li; Guixian Zhu; Chao Li; Hao Lai; Xin Liu; Lei Zhang
Journal:  Nutrients       Date:  2021-11-29       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.